Novel Pyrimidine- And Triazine-Hepcidine Antagonists
The present invention relates to new hepcidin antagonists, pharmaceutical compositions containing them and the use thereof as a drug, in particular for the treatment of iron metabolism disorders such as, in particular, iron deficiency diseases and anaemia, in particular anaemia associated with chronic inflammatory disease (ACD: anaemia of chronic disease and AI: anaemia of inflammation).
-
(2015/09/30)
More Articles about upstream products of 1269626-48-3